Navigation Links
BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
Date:11/19/2012

RALEIGH, N.C., Nov. 19, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 24th Annual Piper Jaffray Healthcare Conference.  The presentation is scheduled for Tuesday, November 27, 2012 at 11:50 a.m. Eastern Time, at The New York Palace in New York City.

(Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO )

Dr. Sirgo will focus on the clinical development program and the market opportunity for BEMA Buprenorphine/Naloxone (BNX) for the treatment of opioid dependence, including the New Drug Application (NDA) submission, which is anticipated to be submitted to the U.S. Food and Drug Administration (FDA) in late second quarter of 2013.  Additionally, Dr. Sirgo will discuss progress made by BDSI and its commercial partner, Endo Health Solutions, with the ongoing Phase 3 clinical studies for BEMA Buprenorphine for the treatment of chronic pain.

The presentation will be webcast live and can be accessed at www.bdsi.com.  For those who are not available to listen to the live broadcast, a replay of the webcast will be available on the BDSI website.

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction.  B
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
2. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
3. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
4. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
5. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
6. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
7. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
8. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
9. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
10. Alimera Sciences Names European Management Team
11. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Endo International plc (NASDAQ: ... announced today that it has commenced an underwritten public ... All ordinary shares in the offering are to be ... also grant to the underwriters of the Offering an ... the date of the final prospectus supplement, to purchase ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
(Date:6/2/2015)... 2, 2015   PDI , a leader ... a series of corporate commitments designed to educate ... the threat of antimicrobial-resistant microorganisms as part of ... Disease Control and Prevention (CDC) and in support ... Antibiotic-Resistant Bacteria. Along with other key ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2
... TORONTO, Nov. 8, 2010 Millennium Research Group ... intelligence, has released its latest surgical navigation systems ... geographies. These two reports cover the breakdown of ... used in neurosurgery, spine, ENT, orthopedic, and soft ...
... SALT LAKE CITY, Nov. 8, 2010 TechniScan, Inc. ... device company engaged in the development and commercialization of an ... its convertible debt. TechniScan entered into amendments with ... extend the maturity date of its entire portfolio of secured ...
Cached Medicine Technology:Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group 2TechniScan, Inc. Announces Restructuring of Convertible Debt 2
(Date:6/3/2015)... evigilo, a world leader in delivering ... new branding by launching a new and enhanced content-centric ... identity: the logo depicting a sun-like image with a ... – To Know. To Act. In time. The color ... A global, borderless approach to alerting and delivering safety ...
(Date:6/2/2015)... Prairie, WI (PRWEB) June 03, 2015 ... for regulated industries such as government, finance and healthcare. ... organization that wants reliable access control to enhance the ... card keyboard requires the secondary authentication of a Smart ... In addition to the smart-chipset card reader, the keyboard ...
(Date:6/2/2015)... MEDIA ADVISORY, June 2, 2015 ... Email: ewallace(at)mentalhealthamerica(dot)net , Breaking News: Congressman Tim Murphy ... at MHA Annual Conference Thursday , Who: Congressman ... address the Mental Health America Annual Conference attendees ... of the Helping Families in Mental Health Crisis ...
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... clinic have unveiled a plan to drive prolific change in ... progress, the TDC Team Dental Clinic offers a ... and an expert management structure for dental tourism. , Partnered ... dental care team is committed to advancing dentistry and has ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations and ... urgent care services in Los Angeles County. The ... California Board of Regents and the Exer Board of ... purchase a minority share of four existing Exer urgent ... Northridge and creates opportunity to grow and develop new, ...
Breaking Medicine News(10 mins):Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:UCLA Health Partners With Exer - More Than Urgent Care 2
... to earn the dubious distinction of becoming a country with ... better emergency facilities for heart patients could save lives, feel ... reports, India is likely to become the heart attack capital ... been spreading like an epidemic and have been affecting the ...
... Onyx Pharmaceuticals, Inc. today announced that Nexavar(R) (sorafenib) ... with hepatocellular carcinoma (HCC), or primary liver cancer ... presented at the 43rd annual meeting of the ... ,The international, Phase 3, placebo-controlled Sorafenib HCC Assessment ...
... two new investigational cancer therapies at the American Society ... a small molecule inhibitor of Poly-ADP Ribose Polymerase (PARP). ... Excision Repair which is a key pathway in the ... mechanism, in tandem with a defective DNA repair gene ...
... 4, 2007 An international team led by MUHC has ... is a common congenital blindness in infants and small children. ... Nature Genetics and is partly funded by the Foundation Fighting ... potential to fast-track a cure for this disease, says lead ...
... The winds of change and a yearning for variety are ... vodka and gin even as the old generation still ... ,As part of the global trend, the consumption of ... up in the subcontinent, thanks to the changing profile of ...
... to a University of Pittsburgh Medical Center (UPMC) study ... of Clinical Oncology (ASCO) in Chicago and published as ... for follicular lymphoma, a slow-growing type of non-Hodgkins lymphoma, ... ,Over 90 percent of study patients responded completely to ...
Cached Medicine News:Health News:Nexavar Significantly Extends Survival of Liver Cancer Patients 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 3Health News:Gene Responsible for Blindness in Infants and Children Identified 2Health News:Young Indians Say Cheers to White Spirits 2Health News:Young Indians Say Cheers to White Spirits 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2
QIAvac 6S provides all manifold components for processing QIAGEN 8-well strips....
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 384-well format...
Medicine Products: